Medtronic has announced CE marking and the pending launch of its new Enlite sensor for use with the company’s continuous glucose monitoring (CGM) systems. The Enlite has demonstrated better accuracy than Medtronic’s previous CGM sensors, and provides greater patient comfort due to its smaller profile. CGM has proven more effective than manual finger-prick testing at enabling patients to manage their blood sugar, and Medtronic hopes that the Enlite’s improved comfort will lead to greater adoption of CGM. The new sensor is designed for use with Medtronic’s MiniMed Paradigm REAL-Time System, MiniMed Paradigm Veo System, Guardian REAL-Time Continuous Glucose Monitoring System, and the iPro2.
From the press release:
Significant design improvements make Enlite Sensor more comfortable and easier to use than the previous sensor. In a clinical study of Enlite Sensor, 85% of patients agreed that sensor insertion was pain free and 86% agreed that the Enlite insertion device was easy to use. The Enlite Sensor is a significantly smaller sensor compared to Medtronic’s previous product – 69% smaller in sensor size by volume, 38% shorter in length. Adding to patient convenience, the Enlite Sensor can be worn on the abdomen and buttocks and used for up to six days.